Strategic Screening and Linkage to Care for Hepatitis B and Hepatitis C in Nigeria

Danjuma Kamlen Adda, Rijimra Ande, Obed Tiwah John, Oscar Facknwie Kahwir, Joyce C. John, Helmina Bantar, Mohammed Umaru and Elkanah O. Sambo
Additional contact information
Danjuma Kamlen Adda: Centre For Initiative and Development (CFID) Taraba
Rijimra Ande: Centre For Initiative and Development (CFID) Taraba
Obed Tiwah John: Centre For Initiative and Development (CFID) Taraba
Oscar Facknwie Kahwir: Centre For Initiative and Development (CFID) Taraba
Joyce C. John: Centre For Initiative and Development (CFID) Taraba
Helmina Bantar: Centre For Initiative and Development (CFID) Taraba
Mohammed Umaru: Centre For Initiative and Development (CFID) Taraba
Elkanah O. Sambo: Department of Biological Sciences, Faculty of Sciences, Taraba State University, Jalingo – Nigeria

International Journal of Research and Innovation in Applied Science, 2023, vol. 8, issue 12, 10-17

Abstract: Background Viral Hepatitis B and C is a major public health concern, leading to 1.1 million deaths globally. The African region accounts for 26% of the global burden and 125,000 associated deaths from hepatitis B and C. Over 20 million Nigerians are living with chronic hepatitis B and C, but more than 80% of the population who are infected do not know their status. Objective: The study aimed to determine the prevalence of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) infections among the general public, pregnant women attending antenatal clinics, healthcare workers, and key populations across three states in Nigeria. Methods: This was a cross-sectional study conducted across three target states and hospitals in Nasarawa, Taraba, and Kano. Participation in the study was voluntary and consent was obtained from participants. Blood sample collection and testing were carried out in line with the WHO guidelines. Frequencies and simple percentage were utilized with the help of IBM SPSS version 25. Results: The prevalence of HBsAg ranged from 4.7% to 7.2% across Healthcare Workers, Key Populations, and Pregnant Women, with an overall prevalence of 5.6% across all target populations. Meanwhile, the prevalence of HCV ranged from 1.9% to 2.8% across General Populations, Healthcare Workers, Key Populations, and Pregnant Women, with an overall prevalence of 2.2% across all target populations. Higher prevalence in specific groups, notably Key Populations, underscores the need for focused interventions to mitigate transmission risks. Conclusion: This study identified HBV and HCV positive patients across target populations/groups in Nigeria. All HBsAg and HBeAg positive pregnant women were identified and enrolled into HBV care to improve Prevention of Mother to Child Transmission of Hepatitis B in Nigeria. All other patients reactive to HBV and HCV were also enrolled into care. In light of these findings, tailored public health initiatives are recommended, encompassing targeted educational campaigns, increased accessibility to healthcare services, and the integration of hepatitis screening into maternal health programs.

Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.rsisinternational.org/journals/ijrias/ ... 8-issue-12/10-17.pdf (application/pdf)
https://rsisinternational.org/journals/ijrias/arti ... atitis-c-in-nigeria/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bjf:journl:v:8:y:2023:i:12:p:10-17

Access Statistics for this article

International Journal of Research and Innovation in Applied Science is currently edited by Dr. Renu Malsaria

More articles in International Journal of Research and Innovation in Applied Science from International Journal of Research and Innovation in Applied Science (IJRIAS)
Bibliographic data for series maintained by Dr. Renu Malsaria ().